文献速递肾血管病与高血压慢性肾脏病遗传性与小管间质肾病

慢性内皮多巴胺受体刺激改善常染色体显性多囊肾病的内皮功能与血流动力学

Chronic endothelial dopamine receptor stimulation improves endothelial function and hemodynamics in autosomal dominant polycystic kidney disease.
PubMed 文献 · Kidney Int · 2024-08-29

4 mg/24h罗替戈汀显著增加一氧化氮释放并改善桡动脉内皮依赖性血流介导舒张,降低主动脉增强指数和脉压,且未影响血浆肌酐、尿素、尿环磷酸腺苷和和肽素。

要点

  • 罗替戈汀4 mg/24h改善ADPKD患者内皮依赖的血管舒张功能。
  • 罗替戈汀4 mg/24h降低主动脉增强指数和脉压,不改变脉搏波传导速度。
  • 罗替戈汀未影响肾功能指标、尿环磷酸腺苷及和肽素水平。

核心结论

  • 在ADPKD患者中,慢性给予罗替戈汀通过恢复血流诱导的一氧化氮释放改善传导动脉内皮功能及血流动力学。
  • 内皮多巴胺5型受体(DR5)激活可能是预防ADPKD心血管并发症的潜在药理途径。

研究设计与样本

  • 另在血管内皮细胞特异性敲除多囊蛋白-1的小鼠中,慢性输注外周DR5激动剂非诺多泮评估肠系膜动脉血流介导舒张和血压。

主要发现

  • 罗替戈汀4 mg/24h使亚硝酸盐水平从10±30 nmol/L升至46±34 nmol/L。
  • 罗替戈汀4 mg/24h使手部皮肤加热诱导的桡动脉内皮依赖性血流介导舒张从16.4±6.3%升至22.5±7.3%。
  • 罗替戈汀4 mg/24h降低主动脉增强指数和脉压,未显著改变全身血流动力学及颈-股脉搏波传导速度。
  • 罗替戈汀未影响血浆肌酐、尿素、尿环磷酸腺苷及和肽素水平。
  • 内皮细胞特异性敲除多囊蛋白-1的小鼠中,慢性输注非诺多泮改善肠系膜动脉血流介导舒张并降低血压。

临床怎么用

  • ADPKD患者短期使用罗替戈汀4 mg/24h可改善内皮功能及部分血流动力学指标,且未观察到肾功能和囊肿生长相关标志物的变化。
  • 内皮DR5激活策略可能用于降低ADPKD心血管并发症风险,但需进一步研究确认长期获益与安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Altered polycystin-mediated endothelial flow mechanosensitivity contributes to the development of hypertension and cardiovascular complications in patients with autosomal dominant polycystic kidney disease (ADPKD). Stimulation of endothelial type 5 dopamine receptors (DR5) can acutely compensate for the endothelial consequences of polycystin deficiency, but the chronic impact of this approach must be evaluated in ADPKD. Nineteen patients with ADPKD on standard of care therapy were randomized to receive a 2-month treatment with the DR agonist rotigotine using transdermal patches, nine at 2 mg/24hours and ten at 4 mg/24hours or while ten were untreated. Rotigotine at the dose of 4 mg/24hours significantly increased nitric oxide release (nitrite levels from 10±30 to 46±34 nmol/L) and radial artery endothelium-dependent flow-mediated dilatation (from 16.4±6.3 to 22.5±7.3%) in response to hand skin heating. Systemic hemodynamics were not significantly modified but aplanation tonometry showed that rotigotine at 4 mg/24hours reduced aortic augmentation index and pulse pressure without affecting carotid-to femoral pulse wave velocity. Plasma creatinine and urea, urinary cyclic AMP, which contributes to cyst growth in ADPKD and copeptin, a surrogate marker of vasopressin, were not affected by rotigotine. In mice with a specific deletion of polycystin-1 in endothelial cells, chronic infusion of the peripheral DR5 agonist fenoldopam also improved mesenteric artery flow-mediated dilatation and reduced blood pressure. Thus, our study demonstrates that in patients with ADPKD, chronic administration of rotigotine improves conduit artery endothelial function through the restoration of flow-induced nitric oxide release as well as hemodynamics suggesting that endothelial DR5 activation may represent a promising pharmacological approach to prevent cardiovascular complications of ADPKD.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Dumont A, Hamzaoui M, Groussard D, et al. Chronic endothelial dopamine receptor stimulation improves endothelial function and hemodynamics in autosomal dominant polycystic kidney disease. Kidney Int. 2024. PMID: 39216660. doi:10.1016/j.kint.2024.08.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。